Brief: Nicox FY Net Revenue Up At EUR 3.3 Million

Nicox SA

20/03/2023 06:36

March 20 (Reuters) - Nicox Sa  NCOX.PA :
    * NICOX REPORTS 2022 FINANCIAL RESULTS AND UPDATES KEY
FUTURE
MILESTONES
    * NET REVENUE FOR FULL YEAR 2022 WAS EUR 3.3 MILLION
(CONSISTING
ENTIRELY OF NET ROYALTIES), COMPARED TO EUR 7.2 MILLION (EUR 2.4
MILLION IN NET ROYALTIES, EUR 4.8 MILLION IN LICENSE PAYMENTS)
FOR FULL YEAR 2021
    * NET LOSS FY 2022 WAS EUR 27.8 MILLION AGAINST EUR 43.8
MILLION
FOR FULL YEAR 2021
    * AS OF DECEMBER 31, 2022, NICOX GROUP HAD FINANCIAL DEBT OF
EUR
24.7 MILLION
    * CASH POSITION OF EUR 27.7 MILLION AS OF DECEMBER 31, 2022
    * OPERATING EXPENSES FOR YEAR 2022 INCREASED TO EUR 27.2
MILLION
FROM EUR 25.1 MILLION FOR PREVIOUS YEAR
    * INITIATION OF TWO NEW PHASE 3B CLINICAL TRIALS
INVESTIGATING THE
DUAL MECHANISM OF ACTION (NITRIC OXIDE AND PROSTAGLANDIN ANALOG)
IN INTRAOCULAR PRESSURE (IOP) LOWERING AND POTENTIAL RETINAL
BENEFITS OF NCX 470: PLANNED IN H1 2023
    * AS OF DECEMBER 31, 2022, CASH AND CASH EQUIVALENTS OF EUR
27.7
MILLION VERSUS EUR 42.0 MILLION AS OF DECEMBER 31, 2021
    * OUTLOOK: EXPECTS DENALI PHASE 3 NCX 470 CLINICAL TRIAL
TOPLINE
RESULTS IN 2025

Source text for Eikon:  ID:nGNX260xRj 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))